Executive Summary
These six contract option exercises total $4,180,930,218 in obligations, with 0/6 defense-related and fully civilian agency focus across HHS, VA, GSA, EPA, and NASA. Dominant themes include health and medical insurance services (HHS MAXIMUS FEDERAL SERVICES, INC. at $2.78B and VA TRIWEST HEALTHCARE ALLIANCE CORP at $928.9M) and engineering/R&D support.
Highest-conviction bullish signal is CACI NSS, LLC's $399.6M GSA engineering delivery order (strength 8/10), signaling durable cost-plus award fee revenue through potential 2026 extension. Key risk is data anomalies including TriWest's $0 outlayed with future performance dates (March 2026) and CACI's negative -$530K outlayed, warranting close funds progress monitoring.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Contract Option Exercises digest from April 17, 2026.
Investment Signals (3)
- MAXIMUS FEDERAL SERVICES, INC. Secures $2.78B HHS Contract Option (MEDIUM)▲
MAXIMUS FEDERAL SERVICES, INC. awarded $2,779,736,793 from Department of Health and Human Services, a high-materiality bullish signal (8/10) in health services despite unknown revenue/pricing details.
- CACI NSS, LLC Wins $399.6M GSA Engineering Delivery Order (HIGH)▲
CACI NSS, LLC (CACI INTERNATIONAL INC subsidiary) secured $399,565,757 obligation (base + options $516.5M) cost-plus award fee delivery order from GSA FEDSIM for DTRA IMAX DA engineering services, with potential extension to June 2026.
- TRIWEST HEALTHCARE ALLIANCE CORP $928.9M VA Insurance Delivery Order (LOW)▲
TRIWEST HEALTHCARE ALLIANCE CORP awarded $928,900,085 firm fixed price VA delivery order for health/medical insurance (one-month March 2026 performance), neutral but material (8/10) with $0 outlayed and post-performance award date.
Risk Flags (3)
- Execution [HIGH RISK]▼
TRIWEST HEALTHCARE ALLIANCE CORP $928.9M VA contract shows high pricing risk (firm fixed price) with $0 outlayed, future March 2026 performance, and award date (2026-04-16) post-dating period end.
- Budget [MEDIUM RISK]▼
CACI NSS, LLC $399.6M GSA contract has negative -$530,151 total outlayed and current end June 29, 2023, despite potential 2026 extension.
- Execution [MEDIUM RISK]▼
LEISNOI DIVERSIFIED-KEMRON 8A JV, LLC $66.7M EPA remediation contract is firm fixed price with high pricing risk, 15% ($9.98M) outlayed over 2.5-year period.
Opportunities (2)
- ◆
CACI NSS, LLC potential extension of $399.6M GSA engineering order to June 2026 via option exercises.
- ◆
LOCKHEED MARTIN CORPORATION two NASA Glenn R&D contracts ($3.62M + $2.39M obligations) with options to $3.87M and $2.67M through 2026-06-30.
Sector Themes (2)
- ◆
HHS $2.78B to MAXIMUS FEDERAL SERVICES, INC. and VA $928.9M firm fixed price delivery order to TRIWEST HEALTHCARE ALLIANCE CORP highlight large-scale health/medical insurance focus (NAICS 524114, PSC G007).
- ◆
GSA $399.6M cost-plus to CACI NSS, LLC for engineering (NAICS 541330) and NASA $6M combined to LOCKHEED MARTIN CORPORATION for space R&D basic research (PSC AR11, NAICS 541715).
Watch List (3)
- 👁
{"entity"=>"TRIWEST HEALTHCARE ALLIANCE CORP", "reason"=>"$928.9M VA contract with $0 outlayed, high pricing risk, and award date post-performance period", "trigger"=>"funds outlay progress; March 2026 performance confirmation"}
- 👁
{"entity"=>"CACI NSS, LLC", "reason"=>"$399.6M GSA order with negative -$530K outlayed and potential 2026 extension", "trigger"=>"option exercises beyond June 29, 2023; outlayed updates"}
- 👁
{"entity"=>"LOCKHEED MARTIN CORPORATION", "reason"=>"Two small NASA contracts ($3.62M + $2.39M) with ~$5.48M combined outlayed and options through 2026-06-30", "trigger"=>"option exercises; performance to 2026-06-30"}
Get daily alerts with 3 investment signals, 3 risk alerts, 2 opportunities and full AI analysis of all 6 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Contract Option Exercises
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals